Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology.

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Christopher D SibleyDeirdre L Church

Abstract

Clinical microbiology laboratories worldwide have historically relied on phenotypic methods (i.e., culture and biochemical tests) for detection, identification and characterization of virulence traits (e.g., antibiotic resistance genes, toxins) of human pathogens. However, limitations to implementation of molecular methods for human infectious diseases testing are being rapidly overcome allowing for the clinical evaluation and implementation of diverse technologies with expanding diagnostic capabilities. The advantages and limitation of molecular techniques including real-time polymerase chain reaction, partial or whole genome sequencing, molecular typing, microarrays, broad-range PCR and multiplexing will be discussed. Finally, terminal restriction fragment length polymorphism (T-RFLP) and deep sequencing are introduced as technologies at the clinical interface with the potential to dramatically enhance our ability to diagnose infectious diseases and better define the epidemiology and microbial ecology of a wide range of complex infections.

References

Jan 1, 1977·Annual Review of Microbiology·D C Savage
Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·G T WalkerD D Shank
Jul 1, 1992·Journal of Clinical Microbiology·S H GohA W Chow
Jul 30, 1992·The New England Journal of Medicine·D A RelmanS Falkow
Apr 11, 1992·Nucleic Acids Research·G T WalkerD P Malinowski
Mar 7, 1991·Nature·J Compton
Sep 1, 1990·Journal of Clinical Microbiology·K H WilsonR C Greene
Dec 25, 1990·Nucleic Acids Research·J Welsh, M McClelland
Jul 1, 1989·Journal of General Microbiology·F M Thomson-CarterT H Pennington
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D Y KwohT R Gingeras
Jan 1, 1987·Methods in Enzymology·K B Mullis, F A Faloona
Jul 1, 1983·The Journal of Infectious Diseases·W E Farrar
Nov 11, 1995·Nucleic Acids Research·P VosM Kuiper
Mar 25, 1995·Lancet·Y Q HuangA E Friedman-Kien
Oct 1, 1995·Clinical Microbiology Reviews·C C KuoJ T Grayston
Oct 1, 1996·Genome Research·C A HeidP M Williams
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·M C MaidenB G Spratt
Jun 10, 1998·Microbiology and Molecular Biology Reviews : MMBR·A van BelkumH Verbrugh
Jun 26, 1999·Science·W F Doolittle
Oct 19, 1999·Critical Reviews in Microbiology·I Brook
May 2, 2000·Journal of Clinical Microbiology·C E CorlessA J Fox
Jun 28, 2000·Nucleic Acids Research·T NotomiT Hase
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Oct 24, 2001·Scandinavian Journal of Infectious Diseases·B MillarP Murphy
Mar 19, 2002·Emerging Infectious Diseases·Simo NikkariDavid A Relman
Apr 16, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B IssartelF Vandenesch

❮ Previous
Next ❯

Citations

Dec 28, 2012·Journal of Clinical Microbiology·Cornelia Lass-FlörlDavid Nachbaur
Jan 18, 2013·Journal of Clinical Microbiology·Michael MililloPatrick McGann
Feb 13, 2014·The Review of Scientific Instruments·N MaloneyM Hegner
Oct 23, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter B McIntyre, Vitali Sintchenko
May 10, 2012·Future Microbiology·Tomasz A LeskiDavid A Stenger
Jun 25, 2013·International Journal of Food Microbiology·Luca CocolinKalliopi Rantsiou
Oct 23, 2014·BMC Genomics·Amirhossein ShamsaddiniRaja Mazumder
Oct 30, 2012·The Medical Clinics of North America·Neel K Krishna, Kenji M Cunnion
Nov 22, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L S DamascenoR M Zancopé-Oliveira
Aug 12, 2014·Journal of Microbiological Methods·Fernanda B AndradeWaldir P Elias
Jun 28, 2015·Journal of Infection and Public Health·Salman S AhmedMehmet Doganay
Nov 14, 2015·Critical Reviews in Food Science and Nutrition·Yao Mianzhi, Nagendra P Shah
Apr 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L van Lieshout, M Roestenberg
May 9, 2015·Applied Microbiology and Biotechnology·Gregor TeglGeorg M Guebitz
Mar 26, 2013·Diagnostic Microbiology and Infectious Disease·Frédéric WalletRené J Courcol
Oct 5, 2013·Diagnostic Microbiology and Infectious Disease·Agnese LupoAndrea Endimiani
Jun 7, 2016·Scientific Reports·Carina Pedrosa CostaSílvia M Rocha
Apr 5, 2013·Clinical Microbiology Reviews·José F Siqueira, Isabela N Rôças
Oct 6, 2016·Science Advances·Amirali AghazadehRichard G Baraniuk
Apr 12, 2013·Expert Review of Proteomics·Brunella PosteraroMaurizio Sanguinetti
Apr 15, 2014·Expert Review of Molecular Diagnostics·Ott SchelerAnts Kurg
Nov 7, 2019·Critical Reviews in Microbiology·Dongsheng HanJinming Li
May 4, 2017·Journal of Biophotonics·Ulrich-Christian SchröderUte Neugebauer
May 10, 2017·Open Forum Infectious Diseases·Sierra C SimmonsJanis E Blair
Feb 23, 2017·BMC Medical Genomics·Jan M FriedmanUNKNOWN Global Alliance for Genomics and Health Regulatory and Ethics Working Group Paediatric Task Team

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genotyping
electrophoresis
ribotyping
amplicon sequencing
chip
nucleic
16S sequencing

Software Mentioned

Ion
UniFrac
eBURST
Diversilab
QIIME
SONS
MLST
SmartGene®

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bartonellosis

Bartonellosis is an infection caused by bacteria in the genus Bartonella and can present as a variety of diseases depending on the organism involved. While asymptomatic infection has been reported, immunocompromised individuals are more susceptible to severe infection. Find the latest research on bartonellosis here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.